DILTIAZEM EXTENDED-
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP21F1163, issued under delivery order SPE2DX15D9383, was awarded to DMS Pharmaceutical Group Inc for the procurement of Diltiazem Extended, identified by NSN 6505015054619. This federal contract for commercial items was managed through the DLA Troop Support Medical Supply Chain FSB and follows standard SF 1449 structures and Part 12 clauses, including specific guidelines for Defense Priority and Allocation Requirements. On August 25, 2026, modification P00001 was issued to the contract, resulting in the total cancellation of CLIN 0001. This action was taken as a termination for the Government's convenience under FAR 52.212-4(i) to address aged and undelivered delivery orders. Consequently, the contract amount was decreased from 0.02 dollars to 0.00 dollars, with no further cost or liability incurred by either party.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
